NBEMS Releases GPAT 2026 Provisional Answer Key, Opens Challenge Window for Candidates

Written By :  sheeba farhat
Published On 2026-03-16 06:00 GMT   |   Update On 2026-03-16 06:00 GMT

New Delhi: The National Board of Examinations in Medical Sciences (NBEMS) has released the provisional answer key, question paper, and recorded responses for the Graduate Pharmacy Aptitude Test. Candidates who appeared for the examination can now access these documents on the official NBEMS website and may raise objections to the provisional answer key within the stipulated time by submitting challenges online along with the prescribed fee.

GPAT-2026 exam was conducted on 7th March 2026 across the country. The recorded responses and provisional answer keys for GPAT-2026 have been published on NBEMS website.

Candidates can access it at NBEMS website under GPAT 2026 webpage using their login credentials. Candidate can click on the tab labelled “Challenge the Provisional Answer Key” after login to access the Question Paper with their recorded responses. To challenge/raise objections to a question/provisional answer click on the tab labelled “Click here to raise a challenge” and submit the challenge with a non-refundable online payment of Rs. 200/- per question/challenge as processing charges.
The provisional answer keys/questions may be challenged between 13.03.2026 (3 PM onwards) to 16.03.2026 (till 3 PM). Only paid challenges made during the stipulated time through the challenge form will be considered. The decision of the NBEMS on the challenges shall be final and no further communication shall be entertained. NBEMS shall not inform the candidates individually about the outcome of their challenges. Challenges submitted outside this window and/or through any mode other than prescribed herein this notice shall not be entertained. Challenges or objections without a valid explanation or reference will not be considered and will be summarily discarded.
The subject matter experts will examine all the challenges received from candidates and then final answer keys for GPAT-2026 will be displayed and result will be declared based on it. No claims pertaining to the difficulty level of a question shall be entertained. This challenge can only be raised by bonafide candidates who had appeared in the examination.
The result of GPAT-2026 shall be compiled based on the final answer keys. No grievance with regard to Answer Key(s) after declaration of result of GPAT-2026 shall be entertained. The marks obtained by a candidate on the basis of the final answer keys will be considered for computation of the result of GPAT-2026 and generation of GPAT scores & merit.

Non Disclosure Agreement

GPAT is a proprietary examination and is conducted only by NBEMS. The contents of this exam are confidential, proprietary and are owned by NBEMS. NBEMS explicitly prohibits the candidate, from reproducing, transmitting or publishing any or some contents of this exam, in whole or in part, in any form or by any means verbal or written, electronic or mechanical for any purpose whatsoever.

NBEMS shall not entertain any request for sharing any content of the examination including answer keys / answer sheets except for the challenge window wherein the provisional answer key along with the questions and recorded responses will be shared with the bonafide candidates who have appeared in the GPAT in order to allow them to challenge the same within the prescribed window

No content of this exam must be shared with friends, acquaintances or third parties including sharing through online means or via social media. Social media includes but not limited to SMS, Whatsapp, Facebook, X, Hangouts, Blogs etc. using either one’s own account or proxy account(s).

It is strictly prohibited for any exam preparation service, coaching institute, or individual to use, disclose, distribute, or solicit content from recent FMGE examinees, or to otherwise provide access to actual questions or answers from the GPAT in any form.

Similarly, candidates are strictly prohibited from sharing, reproducing, or disclosing any part of the GPAT question paper or examination content with any person, test preparation service, coaching institute, or through any social media or online platform.

If there is evidence that a candidate has enrolled in, participated in, or used any exam preparation program, service, or online forum that distributes, provides access to, or uses GPAT content (questions or answers), or has shared such content directly or indirectly, their candidature for GPAT shall be cancelled and their appearance as well as result in GPAT shall be nullified. Such candidates shall be subject to further punitive academic and / or legal action for violation of non-disclosure agreement.

By registering for and / or appearing in GPAT 2026 the candidate explicitly agrees to the above Non-Disclosure Agreement and general terms of use for GPAT 2026 as contained in this Information Bulletin, GPAT 2026 website.

Violation of any act or breach of the same shall be liable for penal action and cancellation of the candidature.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News